22 completed, 2 withdrawn, 1 terminated. 25 Phase 1, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 25 | Completed 22, Withdrawn 2, Terminated 1 |
| Phase 2 | 6 | Completed 4, Terminated 1, Withdrawn 1 |
Follow Resveratrol: new trials by email Literature Review of Resveratrol trials Research Report on Resveratrol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| VIAging Deceleration Trial Using Metformin, Dasatinib, Rapamycin and Nutritional Supplements Study Drugs and Nutritional Supplements - Aging | Phase 1 | Withdrawn | Vitality in Aging Research Group, Inc. | 2022-06-01 | 2022-06-07 | |
| JOTROL PK, Safety, and Food Effect Assessment 200 mg resveratrol as JOTROL, 500 mg resveratrol as JOTROL, 700 mg resveratrol as JOTROL - Pharmacokinetics, Safety | Phase 1 | Completed | Jupiter Orphan Therapeutics Inc. | 24 | 2021-01-21 | 2022-08-12 |
| Metabolism of Bioactive Dietary Polyphenol Preparation (BDPP) Trans-resveratrol, Concord grape juice, Grape seed polyphenol extract - Healthy Control | Phase 1 | Completed | Icahn School of Medicine at Mount Sinai | 84 | 2021-01-19 | 2025-03-03 |
| Resveratrol and Human Hepatocyte Function in Cancer Resveratrol, Placebo - Liver Cancer | Phase 1 / Phase 2 | Withdrawn | University of Louisville | 2015-12-01 | 2017-03-30 | |
| Resveratrol and Cardiovascular Health in the Elderly Resveratrol, Placebo - Vascular Resistance, Hypertension | Phase 1 / Phase 2 | Terminated | National Institute on Aging (NIA) | 73 | 2015-07-14 | 2022-12-23 |
| BDPP Treatment for Mild Cognitive Impairment (MCI) and Prediabetes or Type 2 Diabetes Mellitus (T2DM) grape seed polyphenolic extract, resveratrol - Mild Cognitive Impairment, Alzheimer's Disease | Phase 1 | Completed | Johns Hopkins University | 14 | 2015-06-01 | 2022-07-22 |
| An Open Label Study Evaluating the Effectiveness of Omega Q Plus® Resveratrol at Increasing Blood Levels of CoQ10 Omega Q Plus Resveratrol (with 50mg CoQ10) - CoQ10 Blood Levels, CoQ10 Blood Levels With Statin Use | Phase 1 | Completed | KGK Science Inc. | 50 | 2015-03-01 | 2015-09-23 |
| Healthy Aging Through Functional Food Glyoxalase 1 (Glo1) inducer, Placebo - Glucose Intolerance, Aortic Stiffness | Phase 1 / Phase 2 | Completed | University of Warwick | 32 | 2014-05-01 | 2017-03-06 |
| Effects of Trans-Resveratrol in Endothelial Function in Hypertensive Patients Trans-resveratrol, Placebo - Endothelial Dysfunction | Phase 1 | Completed | Hospital Universitario Pedro Ernesto | 24 | 2013-01-01 | 2015-11-30 |
| Effects of Resveratrol Supplements on Vascular Health in Postmenopausal Women ResA, Resveratrol, Placebo - Cardiovascular Disease | Phase 1 / Phase 2 | Completed | University of California, Davis | 64 | 2012-03-01 | 2017-07-14 |
| Resveratrol in Postmenopausal Women With High Body Mass Index resveratrol, laboratory biomarker analysis - Healthy, no Evidence of Disease | Phase 1 | Completed | National Cancer Institute (NCI) | 46 | 2011-06-01 | 2014-10-09 |
| A Study of Resveratrol as Treatment for Friedreich Ataxia Resveratrol - Friedreich Ataxia | Phase 1 / Phase 2 | Completed | Murdoch Childrens Research Institute | 27 | 2011-04-01 | 2014-01-22 |
| Use of Resveratrol to Decrease Acute Secondary Brain Injury Following Sports-Related Concussions in Boxers Resveratrol, Placebo - Sports Concussion | Phase 1 / Phase 2 | Completed | University of Texas Southwestern Medical Center | 12 | 2011-03-01 | 2021-02-11 |
| Chronic Resveratrol Supplementation in Healthy Humans Resveratrol, Placebo - Healthy | Phase 1 | Completed | Northumbria University | 60 | 2011-02-01 | 2012-10-19 |
| Physiological Effects of Grape Seed Extract in Diastolic Heart Failure grape seed extract (MegaNatural BP, Polyphenolics, Inc.) - Diastolic Heart Failure, Hypertensive Heart Disease | Phase 1 | Completed | University of Michigan | 15 | 2010-10-01 | 2017-06-06 |
| Resveratrol for Improved Performance in the Elderly Placebo, Low dose Resveratrol, High dose Resveratrol - Memory | Phase 1 | Completed | University of Florida | 32 | 2009-11-01 | 2013-12-11 |
| A Clinical Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SRT501 in Subjects With Colorectal Cancer and Hepatic Metastases Placebo, SRT501 - Neoplasms, Colorectal | Phase 1 | Completed | Sirtris, a GSK Company | 9 | 2008-08-19 | 2017-06-14 |
| Resveratrol in Healthy Adult Participants resveratrol, pharmacological study, laboratory biomarker analysis - Healthy, no Evidence of Disease | Phase 1 | Completed | National Cancer Institute (NCI) | 42 | 2008-08-01 | 2014-10-08 |
| Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery resveratrol, pharmacological study, laboratory biomarker analysis - Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum | Phase 1 | Completed | National Cancer Institute (NCI) | 20 | 2006-12-01 | 2014-09-15 |
| Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics With a Single-dose of Levodopa/Benserazide 200/50 mg or With a Single-dose of Levodopa/Benserazide 200/50 mg Plus a Single-dose of Nebicapone 150 mg Placebo, BIA 6-512, Madopar® 250 - Parkinson Disease | Phase 1 | Completed | Bial - Portela C S.A. | 38 | 2006-07-17 | 2017-03-31 |
Showing 20 of 25. Sign in to see all of them.
Parkinson Disease (4) · Hypertension (3) · Colonic Neoplasms (2) · Colorectal Neoplasms (2) · Alzheimer Disease (1) · Aneurysm (1) · Carcinoma, Hepatocellular (1) · Cardiomyopathies (1) · Cardiovascular Diseases (1) · Cognitive Dysfunction (1) · Friedreich Ataxia (1) · Glucose Intolerance (1) · Heart Failure (1) · Heart Failure, Diastolic (1) · Inflammation (1)
Bial - Portela C S.A. (4) · National Cancer Institute (NCI) (4) · Hospital Universitario Pedro Ernesto (1) · Icahn School of Medicine at Mount Sinai (1) · Johns Hopkins University (1) · Jupiter Orphan Therapeutics Inc. (1) · KGK Science Inc. (1) · Murdoch Childrens Research Institute (1) · National Institute on Aging (NIA) (1) · Northumbria University (1) · Sirtris, a GSK Company (1) · University of California, Davis (1) · University of California, Irvine (1) · University of Florida (1) · University of Louisville (1)
United States (14) · United Kingdom (4) · Portugal (3) · Australia (1) · Canada (1) · Germany (1)
Ajoy C Karikkineth, M.D. (1) · Brian G Harbrecht, MD (1) · David O Kennedy, Professor (1) · Dean Brenner (1) · Dean E. Brenner, MD (1) · Elizabeth Anne Weinstock (1) · James Murrough, MD, PhD (1) · Joshua W. Gatson, Ph.D. (1) · Martin Delatycki, MBBS PhD (1) · Martin O Weickert, MD (1) · Paul J Thornalley, BSc PhD (1) · Paul Roserberg, MD (1) · Randall Holcombe, MD (1)
PMID 20935227, PMID 21188121, PMID 24866496, PMID 25115686, PMID 27207552, PMID 35789594
N01CN35158 (2), P30CA023074 (2), P30CA046592 (2), R44AG067907 (1), U19AT010835 (1)